JP3623231B2 - 湿疹／皮膚炎の予防または治療方法 - Google Patents

湿疹／皮膚炎の予防または治療方法 Download PDF

Info

Publication number
JP3623231B2
JP3623231B2 JP50944495A JP50944495A JP3623231B2 JP 3623231 B2 JP3623231 B2 JP 3623231B2 JP 50944495 A JP50944495 A JP 50944495A JP 50944495 A JP50944495 A JP 50944495A JP 3623231 B2 JP3623231 B2 JP 3623231B2
Authority
JP
Japan
Prior art keywords
thr
peptide
eczema
treatment
peptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP50944495A
Other languages
English (en)
Japanese (ja)
Other versions
JPH09506860A (ja
Inventor
ミカエリス，ジュルゲン
エリオット トリグ，ティモスィー
Original Assignee
アドヴァンスト・イミューニット・インク
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by アドヴァンスト・イミューニット・インク filed Critical アドヴァンスト・イミューニット・インク
Publication of JPH09506860A publication Critical patent/JPH09506860A/ja
Application granted granted Critical
Publication of JP3623231B2 publication Critical patent/JP3623231B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/07—Tetrapeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
JP50944495A 1993-09-24 1994-09-26 湿疹／皮膚炎の予防または治療方法 Expired - Fee Related JP3623231B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AUPM144993 1993-09-24
AU1449 1993-09-24
PCT/AU1994/000574 WO1995008338A1 (en) 1993-09-24 1994-09-26 Method for the treatment or prevention of eczema/dermatitis

Publications (2)

Publication Number Publication Date
JPH09506860A JPH09506860A (ja) 1997-07-08
JP3623231B2 true JP3623231B2 (ja) 2005-02-23

Family

ID=3777229

Family Applications (1)

Application Number Title Priority Date Filing Date
JP50944495A Expired - Fee Related JP3623231B2 (ja) 1993-09-24 1994-09-26 湿疹／皮膚炎の予防または治療方法

Country Status (9)

Country Link
US (1) US5798335A (https=)
EP (1) EP0871466B1 (https=)
JP (1) JP3623231B2 (https=)
AU (1) AU697847B2 (https=)
CA (1) CA2172491A1 (https=)
DE (1) DE69433763T2 (https=)
DK (1) DK0871466T3 (https=)
ES (1) ES2218528T3 (https=)
WO (1) WO1995008338A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025123114A1 (pt) * 2023-12-15 2025-06-19 Chemyunion Ltda Composição cosmética, cosmecêutica e/ou farmacêutica, usos e métodos

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4689398A (en) * 1984-06-20 1987-08-25 Ortho Diagnostic Systems Inc. HTLV test using synthetic peptides
US6242564B1 (en) * 1986-06-03 2001-06-05 Candace B. Pert Treatment of tropical spastic paresis with peptide T
US5189022A (en) * 1988-05-27 1993-02-23 The United States Of America As Represented By The Secretary Of Health And Human Services Composition for the treatment of chronic fatigue syndrome
US5063206A (en) * 1988-12-16 1991-11-05 The United States Of Americas As Represented By The Department Of Health And Human Services Compositions having use as treatment of neuropsychiatric deficits
WO1989012067A1 (en) * 1988-05-27 1989-12-14 The United States Of America, As Represented By Th Compositions having use as treatment of psoriasis and neuropsychiatric deficits
DK31991D0 (da) * 1991-02-25 1991-02-25 Carlbiotech Ltd As Peptid og farmaceutisk praeparat indeholdende et saadant peptid
ATE194495T1 (de) * 1992-03-27 2000-07-15 Advanced Immunit T Inc T-peptid und damit verwandte peptide in der behandlung von entzündungen einschliesslich der multiplen sklerose
US5651993A (en) * 1992-11-18 1997-07-29 Yale University Specific immune system modulation

Also Published As

Publication number Publication date
EP0871466A1 (en) 1998-10-21
EP0871466B1 (en) 2004-05-06
DE69433763T2 (de) 2005-04-14
EP0871466A4 (https=) 1998-11-11
AU7735094A (en) 1995-04-10
WO1995008338A1 (en) 1995-03-30
ES2218528T3 (es) 2004-11-16
AU697847B2 (en) 1998-10-15
US5798335A (en) 1998-08-25
JPH09506860A (ja) 1997-07-08
CA2172491A1 (en) 1995-03-30
DE69433763D1 (de) 2004-06-09
DK0871466T3 (da) 2004-08-16

Similar Documents

Publication Publication Date Title
JP6279626B2 (ja) エンドモルフィンのμオピオイド受容体アゴニスト類似体
HK1221477A1 (zh) 多肽及相关化合物的透皮给药系统
FI126143B (en) Polymyxine derivative and its uses
US20100137222A1 (en) Basic Peptides and Their Use as Combined Antibacterial-Antifungine Agents
EP3359179A1 (en) Use of peptides to stimulate the immune system
JP4933440B2 (ja) 経皮デリバリーのための薬剤組成物
ATE392428T1 (de) Arzneimittel enthaltend analgetische peptide
JP3623231B2 (ja) 湿疹／皮膚炎の予防または治療方法
US5036050A (en) Compositions containing thymopentin for topical treatment of skin disorders
JP2023504904A5 (https=)
RU2056432C1 (ru) Производные пептидов или их физиологически приемлемые соли
ES2220915T3 (es) Peptidos lineales y ciclicos para el tratamiento o prevencion de la enfermedad de crohn y/o colitis ulcerosa.
Rivier et al. Gonadotropin releasing hormone antagonists: Novel structures incorporating Nω-cyano modified guanidine moieties
RU95120588A (ru) Циклогексапептиды, их смеси, способ их получения и применения
TW476650B (en) Use of a cytokine regulatory agent to treat rheumatoid arthritis
EP0448811A1 (en) New pharmaceutical composition with anti-inflammatory activity
WO2014075137A1 (en) Peptides incorporating amino-substituted lactams for treatment of retinopathy
WO1998013032A1 (en) Compositions of therapeutic agents suitable for oral administration
RU2002124494A (ru) Ингибиторы интегрина αvβ6
JPH0577654B2 (https=)
BRPI1014274A2 (pt) composições de peptídeos

Legal Events

Date Code Title Description
A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20040601

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20040831

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20040924

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20041018

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20041109

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20041124

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

LAPS Cancellation because of no payment of annual fees